161 related articles for article (PubMed ID: 8087305)
1. Morphologic and immunophenotypic characterization of a cell line derived from liver tissue with Epstein-Barr virus associated post-transplant lymphoproliferative disease.
Randhawa PS; Zeevi A; Alvares C; Gollin S; Agostini R; Yunis E; Saidman S; Contis L; Demetris AJ; Nalesnik MA
In Vitro Cell Dev Biol Anim; 1994 Jun; 30A(6):400-6. PubMed ID: 8087305
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients.
Strazzabosco M; Corneo B; Iemmolo RM; Menin C; Gerunda G; Bonaldi L; Merenda R; Neri D; Poletti A; Montagna M; Del Mistro A; Faccioli AM; D'Andrea E
J Hepatol; 1997 Apr; 26(4):926-34. PubMed ID: 9126809
[TBL] [Abstract][Full Text] [Related]
3. Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus.
Lones MA; Shintaku IP; Weiss LM; Thung SN; Nichols WS; Geller SA
Hum Pathol; 1997 May; 28(5):533-9. PubMed ID: 9158700
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients.
Smets F; Bodeus M; Goubau P; Reding R; Otte JB; Buts JP; Sokal EM
J Hepatol; 2000 Jan; 32(1):100-4. PubMed ID: 10673073
[TBL] [Abstract][Full Text] [Related]
5. The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders.
Delecluse HJ; Kremmer E; Rouault JP; Cour C; Bornkamm G; Berger F
Am J Pathol; 1995 May; 146(5):1113-20. PubMed ID: 7747805
[TBL] [Abstract][Full Text] [Related]
6. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
Quintanilla-MartÃnez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
[TBL] [Abstract][Full Text] [Related]
7. In vitro culture of B-lymphocytes derived from Epstein-Barr-virus-associated posttransplant lymphoproliferative disease: cytokine production and effect of interferon-alpha.
Randhawa P; Whiteside T; Zeevi A; Nalesnik M; Alvares C; Gollin SM; Demetris J; Locker J
In Vitro Cell Dev Biol Anim; 1997; 33(10):803-8. PubMed ID: 9466686
[TBL] [Abstract][Full Text] [Related]
8. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
[TBL] [Abstract][Full Text] [Related]
9. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation.
Armes JE; Angus P; Southey MC; Battaglia SE; Ross BC; Jones RM; Venter DJ
Cancer; 1994 Nov; 74(9):2436-41. PubMed ID: 7922997
[TBL] [Abstract][Full Text] [Related]
10. Characterization and comparison of two newly established Epstein-Barr virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines. EBV-negative cell line with a low level of expression of ICAM-1 molecule and EBV-positive cell line with a high level of expression of ICAM-1 molecule.
Abe M; Tasaki K; Tominaga K; Fukuhara S; Imai S; Osato T; Wakasa H
Cancer; 1992 Feb; 69(3):763-71. PubMed ID: 1309680
[TBL] [Abstract][Full Text] [Related]
11. EBV-NK cells interactions and lymphoproliferative disorders.
Kanegane H; Yachie A; Miyawaki T; Tosato G
Leuk Lymphoma; 1998 May; 29(5-6):491-8. PubMed ID: 9643562
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus infections in children after transplantation of the small intestine.
Finn L; Reyes J; Bueno J; Yunis E
Am J Surg Pathol; 1998 Mar; 22(3):299-309. PubMed ID: 9500771
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-associated lymphoproliferative disorders in oral cavity after heart transplantation: report of a case.
Chang H; Wu JD; Cheng KK; Tseng HH
J Formos Med Assoc; 1994 Apr; 93(4):332-6. PubMed ID: 7914777
[TBL] [Abstract][Full Text] [Related]
14. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus infection and malignant lymphomas in liver transplant recipients.
Niedobitek G; Mutimer DJ; Williams A; Whitehead L; Wilson P; Rooney N; Young LS; Hübscher SG
Int J Cancer; 1997 Nov; 73(4):514-20. PubMed ID: 9389565
[TBL] [Abstract][Full Text] [Related]
16. EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease.
McKnight JL; Cen H; Riddler SA; Breinig MC; Williams PA; Ho M; Joseph PS
Leuk Lymphoma; 1994 Sep; 15(1-2):9-16. PubMed ID: 7858507
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients.
Sokal EM; Caragiozoglou T; Lamy M; Reding R; Otte JB
Transplantation; 1993 Dec; 56(6):1394-8. PubMed ID: 8279009
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-related post-transplant lymphoproliferative disorder with t(9;14)(p11-12;q32).
Fasan O; Willmott C; Czepulkowski B; Baker A; Rees D; Salisbury J; Mufti GJ
Cancer Genet Cytogenet; 2003 Apr; 142(2):134-6. PubMed ID: 12699890
[TBL] [Abstract][Full Text] [Related]
19. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.
Sokal EM; Antunes H; Beguin C; Bodeus M; Wallemacq P; de Ville de Goyet J; Reding R; Janssen M; Buts JP; Otte JB
Transplantation; 1997 Nov; 64(10):1438-42. PubMed ID: 9392308
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 production by a B-cell line derived from human post-transplant lymphoproliferative disease.
Randhawa P; Nalesnik M; Demetris J; Zeevi A
Hematol Oncol; 1995; 13(1):13-8. PubMed ID: 7750924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
